col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


160 Results       Page 1

 [1] 
Informa UK (Taylor & Francis): Expert Review of Vaccines
  original article Date Title Authors   All Authors
1 [GO] 2024―May―02 Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study Rong Tang, Ying Zeng, Yu Zhou, Qi Liang, Wei Kang, Zhonghua Yang, et al. (+5)
2 [GO] 2024―Apr―24 Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies Timo Ulrichs, Morgane Rolland, Jianhong Wu, Marta C Nunes, Clotilde El Guerche-Séblain, Ayman Chit
3 [GO] 2024―Apr―05 Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary Shanti Pather, Alexander Muik, Ruben Rizzi, Federico Mensa
4 [GO] 2024―Mar―26 Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies Abundio Balgos, Suad AI Hannawi, Wen-Li Chen, Alaa Abuquta, Linda Safeldin, Aala Hassan, et al. (+16)
5 [GO] 2024―Mar―22 Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 omicron variant Gabiria Pastore, Jacopo Polvere, Fabio Fiorino, Simone Lucchesi, Giorgio Montesi, Ilaria Rancan, et al. (+8)
6 [GO] 2024―Feb―27 Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, Chihiro Takahashi, Jingyan Yang, Koji Wada, Naohiro Yonemoto
7 [GO] 2024―Feb―20 Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis Alberto San Francisco Ramos, Carolina Liu Sanchez, Tatiana Bovill Rose, David Smith, Natasha Thorn, Eva Galiza, et al. (+6)
8 [GO] 2024―Feb―19 Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine Viravarn Luvira, Punnee Pitisuttithum
9 [GO] 2024―Jan―30 Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS) Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Mayumi Terada, Shingo Masuda, et al. (+26)
10 [GO] 2023―Dec―08 Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data Yiming Li, Sori K Lundin, Jianfu Li, Wei Tao, Yifang Dang, Yong Chen, Cui Tao
11 [GO] 2023―Dec―04 Modelling the potential public health impact of different COVID-19 vaccination strategies with an adapted vaccine in Singapore Ben Yarnoff, Karan Thakkar, Julia Spinardi, Moe H. Kyaw, Jingyan Yang, Carlos Fernando Mendoza, et al. (+4)
12 [GO] 2023―Nov―27 A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson’s disease Hui Han, Dan Zhao, Xinru Fang, Wenming Yang, Mengli Wang, Qianzhuo Liu, et al. (+7)
13 [GO] 2023―Oct―25 Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older Yingping Chen, Xinpei Zhang, Lihui Gong, Zhenzhen Liang, Xiaosong Hu, Bo Xing, et al. (+4)
14 [GO] 2023―Oct―25 Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination Ruyun Gao, Cuiling Zheng, Mengwei Yang, Liyuan Dai, Chen Chen, Jiarui Yao, et al. (+4)
15 [GO] 2023―Oct―19 Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study Yajie Gong, Xi Zhang, Xue Han, Baolan Chen, Yingxia Xu, Jitian Huang, et al. (+12)
16 [GO] 2023―Oct―16 No observable influence of COVID-19 inactivated vaccines on pregnancy and birth outcomes in the first trimester of gestation Ting Du, Qiuxia Qu, Yawen Zhang, Qin Huang
17 [GO] 2023―Oct―16 Risks of low vaccination coverage and strategies to prevent the resurgence of vaccine-preventable diseases in infants in the COVID-19 pandemic scenario: recommendations for Latin America and the Caribbean by the group of experts on infant immunization for Latin America Maria L. Avila Agüero, Jose Brea Del Castillo, Luiza Helena Falleiros-Arlant, Eitan Berezín, Jose Cassio de Moraes, Carlos Torres-Martínez, et al. (+7)
18 [GO] 2023―Sep―19 Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine Angel Shabu, Prasad S Nishtala
19 [GO] 2023―Aug―22 Impact of COVID-19 pandemic on flu vaccine uptake in healthcare workers in Europe: a systematic review and meta-analysis Silvio Tafuri, Francesco Paolo Bianchi, Eustachio Cuscianna, Donato Rizzi, Noemi Signorile, Antonio Daleno, Giovanni Migliore
20 [GO] 2023―Jul―28 A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov Shen-Yu Wang, Wen-Qing Liu, Yu-Qing Li, Jing-Xin Li, Feng-Cai Zhu
21 [GO] 2023―Jul―11 Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial Yan-Fei Wu, Ming-Wei Wei, Rui-Jie Wang, Xi-Ling Guo, Hong-Xing Pan, Ya-Chun Gao, et al. (+8)
22 [GO] 2023―Jul―07 Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era Shanti Pather, Alexander Muik, Ruben Rizzi, Federico Mensa
23 [GO] 2023―Jul―07 Risk of herpes zoster following mRNA COVID-19 vaccine administration Ana Florea, Jun Wu, Lei Qian, Bruno Lewin, Lina S. Sy, I-Chun Lin, et al. (+2)
24 [GO] 2023―Jun―30 Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines Anthony M. Marchese, Raj Kalkeri, Muruga Vadivale, Nungruthai Suntronwong, Seth Toback, Yong Poovorawan
25 [GO] 2023―Jun―08 Understanding COVID-19 vaccination decisions during pregnancy and while breastfeeding in a Canadian province Kate Lee, Monica Surti, Marcia Bruce, Greis Beharaj, Gerald F. Giesbrecht, Eliana Castillo
26 [GO] 2023―May―30 From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access Peter J. Hotez, Rakesh Adhikari, Wen-Hsiang Chen, Yi-Lin Chen, Portia Gillespie, Nelufa Y. Islam, et al. (+17)
27 [GO] 2023―May―23 Changes in vaccine administration trends across the life-course during the COVID-19 pandemic in the United States: a claims database study Amanda L. Eiden, Anthony DiFranzo, Alexandra Bhatti, H. Echo Wang, Goran Bencina, Lixia Yao, et al. (+3)
28 [GO] 2023―May―10 Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines Xiaoqing Guan, Yang Yang, Lanying Du
29 [GO] 2023―May―03 Safety outcomes associated with the Moderna COVID-19 vaccine (mRNA-1273): a literature review Angel Shabu, Prasad S. Nishtala
30 [GO] 2023―May―03 Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses Giorgia Tiozzo, Timon Louwsma, Stefan R A Konings, Gerard T Vondeling, Judith Perez Gomez, Maarten J Postma, Roel D Freriks
31 [GO] 2023―Apr―20 Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses Patrick DMC Katoto, Mireille AM Kakubu, Jacques L. Tamuzi, Amanda S. Brand, Adaeze Ayuk, Liliane N. Byamungu, et al. (+2)
32 [GO] 2023―Apr―05 Monkeypox pandemic containment: does the ACAM2000 vaccine play a role in the current outbreaks? Basant E. Katamesh, Maysa Madany, Fatma Labieb, Abdelaziz Abdelaal
33 [GO] 2023―Mar―15 Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews Thuan Tong Tan, Heng Joo Ng, Barnaby Young, Behram Ali Khan, Vikram Shetty, Nura Azmi, Steve Clissold
34 [GO] 2023―Mar―10 Shoulder injury following COVID-19 vaccine administration: a case series and proposed diagnostic algorithm Nikki Petrakis, Mel Addison, Bianca Penak, Silja Schrader, John Mallard, Hazel J Clothier, et al. (+3)
35 [GO] 2023―Mar―08 Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS) Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Mayumi Terada, Takayasu Ito, et al. (+17)
36 [GO] 2023―Feb―23 Digital health technology used in emergency large-scale vaccination campaigns in low- and middle-income countries: a narrative review for improved pandemic preparedness Paula Mc Kenna, Lindsay A. Broadfield, Annik Willems, Serge Masyn, Theresa Pattery, Ruxandra Draghia-Akli
37 [GO] 2023―Feb―20 Can protein vaccines for COVID-19 win over the vaccine-hesitant? E. Adrianne Hammershaimb, Milagritos D. Tapia
38 [GO] 2023―Feb―20 COVID-19 vaccines: the start of a new era in regulation? Peter W. Marks
39 [GO] 2023―Jan―30 Understanding the mechanisms for COVID-19 vaccine’s protection against infection and severe disease Huijie Yang, Ying Xie, Changgui Li
40 [GO] 2023―Jan―23 “Vaccinate my village” strategy in Malawi: an effort to boost COVID-19 vaccination Sanjay Singhal, Ghanshyam Sethy, Mike Nenani Chisema, Lokesh Sharma, Krupal Joshi, Patrick Omar Nicks, et al. (+5)
41 [GO] 2022―Dec―17 Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela Di Fusco, Timothy Lee Wiemken, et al. (+3)
42 [GO] 2022―Dec―15 Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L. Nguyen, Libby Hamson, et al. (+3)
43 [GO] 2022―Dec―09 Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review Cristian Sandoval, Daniela Guerrero, Joham Muñoz, Karina Godoy, Vanessa Souza-Mello, Jorge Farías
44 [GO] 2022―Nov―22 Cardiovascular safety of COVID-19 studies: vaccines in real-world a systematic review and meta-analysis Yafei Chang, Guoli Lv, Chao Liu, Erwen Huang, Bin Luo
45 [GO] 2022―Nov―17 Success of nano-vaccines against COVID-19: A transformation in nanomedicine Manoj Kumar Sarangi, Sasmita Padhi, Gautam Rath, Sitansu Sekhar Nanda, Dong Kee Yi
46 [GO] 2022―Nov―04 Expert Review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Sunate Chuenkitmongkol, et al. (+16)
47 [GO] 2022―Oct―15 Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis Angela Meggiolaro, Monica Sane Schepisi, Sara Farina, Carolina Castagna, Alessia Mammone, Andrea Siddu, et al. (+3)
48 [GO] 2022―Sep―05 Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs Oluyemisi Falope, Mawuli K. Nyaku, Ciara O’Rourke, Lindsay V. Hermany, Brittany Plavchak, Josephine Mauskopf, et al. (+2)
49 [GO] 2022―Sep―01 Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above Zhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, Peng-Fei Jin, Shi-Hua Ma, Hong-Xing Pan, et al. (+12)
50 [GO] 2022―Aug―30 Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm? Kyu-Bin Oh, T. Mark Doherty, Volker Vetter, Paolo Bonanni
51 [GO] 2022―Aug―25 Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza Ekaterina Stepanova, Irina Isakova-Sivak, Larisa Rudenko
52 [GO] 2022―Aug―22 Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2 Igor Age Kos, Maximilian Kiefer, Katharina Brill, Onur Cetin, Joerg Thomas Bittenbring, Manfred Ahlgrimm, et al. (+7)
53 [GO] 2022―Aug―20 Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks Abdolreza Esmaeilzadeh, Armin Jahani Maleki, Amirhosein Moradi, Amir Siahmansouri, Mohammad Javad Yavari, Parsa Karami, Reza Elahi
54 [GO] 2022―Aug―18 COVID-19 and vaccination: myths vs science Vivek P. Chavda, Yangmin Chen, Jayant Dave, Zhe-Sheng Chen, Subhash C. Chauhan, Murali M. Yallapu, et al. (+4)
55 [GO] 2022―Aug―15 Further implications on the global real-world vaccine effectiveness against SARS-CoV-2 Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Sunate Chuenkitmongkol, et al. (+13)
56 [GO] 2022―Aug―11 COVID-19 vaccine design and vaccination strategy for emerging variants Vivek P Chavda, Vasso Apostolopoulos
57 [GO] 2022―Aug―05 Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management Vivek P Chavda, Aayushi B. Patel, Lalitkumar K Vora, Vasso Apostolopoulos, Bruce D. Uhal
58 [GO] 2022―Aug―04 Vaccines against SARS-CoV-2 variants and future pandemics Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, Sang Gu Kang, Seunghyup Song, Young Hun Kim, et al. (+5)
59 [GO] 2022―Jul―25 Personal and contextual determinants of COVID-19 vaccination intention: a vignette study Sofie Morbée, Joachim Waterschoot, Vincent Yzerbyt, Olivier Klein, Olivier Luminet, Mathias Schmitz, et al. (+4)
60 [GO] 2022―Jul―21 Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in China Li-na Yan, Zhong-xin Zhao, Zhen-dong Wang, Xiao Xiao, Pan-pan Liu, Wen-kang Zhang, et al. (+4)
61 [GO] 2022―Jul―20 COVID-19 vaccination and mask wearing behaviors in the United States, August 2020 - June 2021 Christopher J Floyd, Grace E Joachim, Matthew L Boulton, Jon Zelner, Abram L Wagner
62 [GO] 2022―Jul―13 The effect of COVID-19 mRNA vaccines against postvaccination laboratory-confirmed SARS-CoV-2 infection, symptomatic COVID-19 infection, hospitalization, and mortality rate: a systematic review and meta-analysis Hamid Reza Baradaran, Hojat Dehghanbanadaki, Farhad Moradpour, Babak Eshrati, Ghobad Moradi, Mobin Azami, et al. (+3)
63 [GO] 2022―Jul―12 COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis Francesco Paolo Bianchi, Pasquale Stefanizzi, Maria Cristina Di Gioia, Nazario Brescia, Sabrina Lattanzio, Silvio Tafuri
64 [GO] 2022―Jul―11 Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States Sophia Hatziantoniou, Cleo Anastassopoulou, George Lazaros, Konstantinos Vasileiou, Costas Tsioufis, Athanasios Tsakris
65 [GO] 2022―Jul―07 Comparing Reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis Natalina Sutton, Alberto San Francisco Ramos, Emily Beales, David Smith, Sabina Ikram, Eva Galiza, et al. (+2)
66 [GO] 2022―Jul―06 Reactogenicity, immunogenicity, and humoral immune response dynamics after the third dose of heterologous COVID-19 vaccines in participants fully vaccinated with inactivated vaccine Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, et al. (+3)
67 [GO] 2022―Jun―28 Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study Toshio Naito, Nao Tsuchida, Susumu Kusunoki, Yoshihiro Kaneko, Morikuni Tobita, Satoshi Hori, Suminobu Ito
68 [GO] 2022―Jun―27 COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis Francesco Paolo Bianchi, Pasquale Stefanizzi, Nazario Brescia, Sabrina Lattanzio, Andrea Martinelli, Silvio Tafuri
69 [GO] 2022―Jun―24 Expert Review on global real-world vaccine effectiveness against SARS-CoV-2 Sunate Chuenkitmongkol, Rontgene Solante, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Dung Do-Van, et al. (+12)
70 [GO] 2022―Jun―13 Making COVID-19 mRNA vaccines accessible: challenges resolved Sarfaraz K. Niazi
71 [GO] 2022―Jun―13 SARS-CoV-2 the ASIA virus (autoimmune/autoinflammatory syndrome induced by adjuvants), the risk of infertility and vaccine hesitancy Rohan Ameratunga
72 [GO] 2022―Jun―02 Nonhuman primate models for evaluation of SARS-CoV-2 vaccines Jessica A. Neil, Maryanne Griffith, Dale I. Godfrey, Damian F. J. Purcell, Georgia Deliyannis, David Jackson, et al. (+3)
73 [GO] 2022―May―23 The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19? Amresh Kumar, Amit Ladha, Ankita Choudhury, Abu Md Ashif Ikbal, Bedanta Bhattacharjee, Tanmay Das, et al. (+10)
74 [GO] 2022―May―20 Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo? Jonny Jonny, Terawan Agus Putranto, Enda Cindylosa Sitepu, Raoulian Irfon
75 [GO] 2022―May―19 COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population-based cohort study Valeria Fano, Enzo Coviello, Dario Consonni, Alessandro Agresta, Nicola Orsini, Alessia Crielesi, et al. (+7)
76 [GO] 2022―May―13 Safety profile of COVID-19 vaccines, preventive strategies and patient management M. Mukhyaprana Prabhu, Subish Palaian, Mukhtar Ansari
77 [GO] 2022―May―11 Responding to new challenges: is there a need to relook and revise our COVID-19 vaccination strategy? Vipin M. Vashishtha, Puneet Kumar
78 [GO] 2022―May―06 Reply to: Correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination” Michele Gringeri, Vera Battini, Gianluca Cammarata, Giulia Mosini, Greta Guarnieri, Chiara Leoni, et al. (+4)
79 [GO] 2022―Apr―27 Repeated vaccination and ‘vaccine exhaustion’: relevance to the COVID-19 crisis Md Anwarul Azim Majumder, Mohammed S. Razzaque
80 [GO] 2022―Apr―26 Correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination” Rujittika Mungmungpuntipantip, Viroj Wiwanitkit
81 [GO] 2022―Apr―15 Efficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction Claudio Marabotti
82 [GO] 2022―Apr―07 Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the Delta variant in Italy, 19 July to 12 December 2021 Massimo Fabiani, Maria Puopolo, Antonietta Filia, Chiara Sacco, Alberto Mateo-Urdiales, Stefania Spila Alegiani, et al. (+23)
83 [GO] 2022―Apr―04 Influence of social media on the public perspectives of the safety of COVID-19 vaccines Sai Krishna Gudi, Sophia M. George, Jimmy Jose
84 [GO] 2022―Mar―22 Current status of COVID-19 vaccination: safety and liability concern for children, pregnant and lactating women Swagat Kumar Das, Manish Paul, Bikash Chandra Behera, Hrudayanath Thatoi
85 [GO] 2022―Mar―14 Global prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis Maryam Nikpour, Mahdi Sepidarkish, Shabnam Omidvar, Mojgan Firouzbakht
86 [GO] 2022―Feb―22 Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis Michele Gringeri, Vera Battini, Gianluca Cammarata, Giulia Mosini, Greta Guarnieri, Chiara Leoni, et al. (+4)
87 [GO] 2022―Feb―14 Clinical development and approval of COVID-19 vaccines Ulrich Kalinke, Dan H. Barouch, Ruben Rizzi, Eleni Lagkadinou, Özlem Türeci, Shanti Pather, Pieter Neels
88 [GO] 2022―Feb―03 Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis Chia-Wei Chu, Zhu Liduzi Jiesisibieke, Yu-Pei Yang, Pao-Chu Wu, Hong-Liang Lin, Tao-Hsin Tung
89 [GO] 2022―Feb―03 COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies Manuela Di Fusco, Jay Lin, Shailja Vaghela, Melissa Lingohr-Smith, Jennifer L. Nguyen, Thomas Scassellati Sforzolini, et al. (+3)
90 [GO] 2022―Jan―25 Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis Ataru Igarashi, Yosuke Nakano, Mariko Yoneyama-Hirozane
91 [GO] 2022―Jan―20 Immunization in pregnancy to protect pregnant people and their newborns against COVID-19 Mahin Delara, Manish Sadarangani
92 [GO] 2022―Jan―06 COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa Charles S Wiysonge, Samuel M Alobwede, Patrick de Marie C Katoto, Elvis B Kidzeru, Evelyn N Lumngwena, Sara Cooper, et al. (+3)
93 [GO] 2022―Jan―04 Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital Marta (M) Valera-Rubio, María Isabel (MI) Sierra-Torres, Raquel (R) Castillejo García, Jaime (J) Cordero-Ramos, María Reyes (MR) López-Márquez, Óscar (O) Cruz-Salgado, Miguel Ángel (MA) Calleja-Hernández
94 [GO] 2022―Jan―02 From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign Jiahao Wang, He Zhu, Xiaozhen Lai, Haijun Zhang, Yingzhe Huang, Huangyufei Feng, et al. (+4)
95 [GO] 2021―Dec―30 Looking to the future: is a universal coronavirus vaccine feasible? Vipin M. Vashishtha, Puneet Kumar
96 [GO] 2021―Dec―28 Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China Peng Zhang, Kaisheng Fan, Hanwen Guan, Qiao Zhang, Xuejing Bi, Yangmu Huang, et al. (+6)
97 [GO] 2021―Dec―27 Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines Pedro L. Moro, Michael M. McNeil
98 [GO] 2021―Dec―24 Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy Aida Bianco, Giorgia Della Polla, Silvia Angelillo, Concetta P Pelullo, Francesca Licata, Italo F. Angelillo
99 [GO] 2021―Dec―23 The road to achieving herd immunity: factors associated with Singapore residents’ uptake and hesitancy of the COVID-19 vaccination Li Feng Tan, Chan Yiong Huak, Isabel Siow, Angel Justina Tan, Preetha Menon Venugopalan, Arthi Premkumar, et al. (+2)
100 [GO] 2021―Dec―23 The race for a COVID-19 vaccine: where are we up to? Md Kamal Hossain, Majid Hassanzadeganroudsari, Jack Feehan, Vasso Apostolopoulos
101 [GO] 2021―Dec―16 Predicting the risk of severe COVID-19 outcomes in primary care: development and validation of a vulnerability index for equitable allocation of effective vaccines Francesco Lapi, Alexander Domnich, Ettore Marconi, Alessandro Rossi, Ignazio Grattagliano, Erik Lagolio, et al. (+5)
102 [GO] 2021―Dec―13 COVID-19 vaccine trials and sex-disaggregated data Musaddique Hussain, Mehwish Fatima, Shahid Muhammad Iqbal, Muhammad Asif, Malik Saad Ullah, Imran Mukhtar, et al. (+13)
103 [GO] 2021―Dec―13 Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China Tao-Hsin Tung, Xiao-Qing Lin, Yan Chen, Mei-Xian Zhang, Jian-Sheng Zhu
104 [GO] 2021―Dec―08 Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic Emrah Altindis
105 [GO] 2021―Dec―08 Relationship between attitudes toward the effectiveness of vaccine, concerns about adverse reactions, and proactively taking SARS-Cov-2 vaccine for family among medical workers in Taizhou, China Chengwen Luo, Mei-Xian Zhang, Gui-Feng Shi, Hai-Xiao Chen, Tao-Hsin Tung
106 [GO] 2021―Dec―02 Overcoming COVID-19 vaccine hesitancy: can Australia reach the last 20 percent? Jessica Kaufman, Jane Tuckerman, Margie Danchin
107 [GO] 2021―Nov―30 Examining the validity of the drivers of COVID-19 vaccination acceptance scale using Rasch analysis Chia-Wei Fan, Jung-Sheng Chen, Frimpong-Manso Addo, Emma Sethina Adjaottor, Gifty Boakye Amankwaah, Cheng-Fang Yen, et al. (+2)
108 [GO] 2021―Nov―29 Is vaccination necessary for COVID-19 patients? A retrospective cohort study investigating reinfection rates and symptomatology in a tertiary hospital Ferhat Arslan, Burcu Isık Goren, Begumhan Baysal, Haluk Vahaboğlu
109 [GO] 2021―Nov―20 What are the challenges faced by COVID-19 vaccines? Mohnad Abdalla, Amr Ahmed El-Arabey, Xinyi Jiang
110 [GO] 2021―Nov―17 Eyedrop vaccination: an immunization route with promises for effective responses to pandemics Jihei Sara Lee, Sangchul Yoon, Soo Jung Han, Eun-Do Kim, Jiyeon Kim, Hae-Sol Shin, Kyoung Yul Seo
111 [GO] 2021―Nov―11 COVID-19 vaccine equity: a health systems and policy perspective Remco van de Pas, Marc-Alain Widdowson, Raffaella Ravinetto, Prashanth N Srinivas, Theresa J. Ochoa, Thierno Oumar Fofana, Wim Van Damme
112 [GO] 2021―Oct―28 COVID-19 Vaccine Mandate for Healthcare Workers in the United States: A Social Justice Policy Kobina Hagan, Rebecca Forman, Elias Mossialos, Paul Ndebele, Adnan A. Hyder, Khurram Nasir
113 [GO] 2021―Oct―26 Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants Bhaswati Chatterjee, Suman S. Thakur
114 [GO] 2021―Oct―13 SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways Daniel Mekonnen, Hylemariam Mihiretie Mengist, Tengchuan Jin
115 [GO] 2021―Oct―07 Effects of the COVID-19 pandemic on routine pediatric vaccination in Brazil Victor Santana Santos, Sarah Cristina Fontes Vieira, Ikaro Daniel de Carvalho Barreto, Vanessa Tavares de Gois-Santos, Ariel Oliveira Celestino, Carla Domingues, et al. (+2)
116 [GO] 2021―Oct―01 COVID-19 vaccination in pregnant and lactating women: a systematic review Raffaele Falsaperla, Guido Leone, Maria Familiari, Martino Ruggieri
117 [GO] 2021―Sep―28 DNA vaccines for SARS-CoV-2: towards third generation vaccination era Vivek P Chavda, Radhika Pandya, Vasso Apostolopoulos
118 [GO] 2021―Sep―10 Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh Raeed Jamiruddin, Ahsanul Haq, Mohib Ullah Khondoker, Tamanna Ali, Firoz Ahmed, Shahad Saif Khandker, et al. (+11)
119 [GO] 2021―Aug―20 To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination Nan-Chang Chiu, Hsin Chi, Yu-Kang Tu, Ya-Ning Huang, Yu-Lin Tai, Shun-Long Weng, et al. (+4)
120 [GO] 2021―Aug―20 COVID-19 vaccine coverage, concerns, and preferences among Chinese ICU clinicians: a nationwide online survey Weifeng Huang, Xiaoping Shao, Abram L. Wagner, Yan Chen, Baichu Guan, Matthew L. Boulton, et al. (+3)
121 [GO] 2021―Aug―18 The associations of geographic location and perceived risk of infection with the intentions to get vaccinated against COVID-19 in China Rize Jing, Li Li, Jia Guo, Yifan Song, Shufan Geng, Jiaohao Wang, et al. (+7)
122 [GO] 2021―Aug―11 Determinants of parental hesitancy to vaccinate their children against COVID-19 in China Mei-Xian Zhang, Xiao-Qing Lin, Yan Chen, Tao-Hsin Tung, Jian-Sheng Zhu
123 [GO] 2021―Aug―09 Sars-Cov-2 virus and vaccination; biological and statistical framework Ferhat Arslan, Handan Ankaralı
124 [GO] 2021―Aug―04 Understanding Covid-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change? Tehniat F Ahmed, Affan Ahmed, Sheharyar Ahmed, Haadi U Ahmed
125 [GO] 2021―Aug―02 COVID-19 vaccines approved in the European Union: current evidence and perspectives Stefania Bellino
126 [GO] 2021―Jul―27 Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2? Divakar Sharma
127 [GO] 2021―Jul―12 COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Sara Cooper, Heidi van Rooyen, Charles Shey Wiysonge
128 [GO] 2021―Jul―05 Should we be vaccinating children against COVID-19 in high-income countries? Grace Li, Adam Finn, Andrew J Pollard
129 [GO] 2021―Jul―05 Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh A.B.M. Muksudul Alam, Md. Anwarul Azim Majumder, Mainul Haque, Fatema Ashraf, Mohib Ullah Khondoker, Saidur Rahman Mashreky, et al. (+20)
130 [GO] 2021―Jun―26 COVID-19 vaccines and thrombosis with thrombocytopenia syndrome Chih-Cheng Lai, Wen-Chien Ko, Chih-Jung Chen, Po-Yen Chen, Yhu-Chering Huang, Ping-Ing Lee, Po-Ren Hsueh
131 [GO] 2021―Jun―26 COVID-19 vaccines: concerns beyond protective efficacy and safety Chih-Cheng Lai, I-Tzu Chen, Chien-Ming Chao, Ping-Ing Lee, Wen-Chien Ko, Po-Ren Hsueh
132 [GO] 2021―Jun―05 Reported Adverse Effects following COVID-19 Vaccination at a Tertiary Care Hospital, Focus on Cerebral Venous Sinus Thrombosis (CVST) Laila Carolina Abu Esba, Majed Al Jeraisy
133 [GO] 2021―Jun―03 COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials Wenping Gong, Ashok Aspatwar, Shuyong Wang, Seppo Parkkila, Xueqiong Wu
134 [GO] 2021―May―20 Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations Daniele Focosi, Massimo Franchini
135 [GO] 2021―May―14 The COVID-19 pandemic momentum: can it be used to support improvements in healthcare worker influenza vaccination Holly Seale
136 [GO] 2021―May―02 Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China Mei-Xian Zhang, Tong-Tong Zhang, Gui-Feng Shi, Feng-Min Cheng, Yan-Ming Zheng, Tao-Hsin Tung, Hai-xiao Chen
137 [GO] 2021―Apr―26 Surveying willingness towards SARS-CoV-2 vaccination of healthcare workers in Italy Gabriella Di Giuseppe, Concetta P Pelullo, Giorgia Della Polla, Maria V Montemurro, Francesco Napolitano, Maria Pavia, Italo F. Angelillo
138 [GO] 2021―Apr―26 The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines? Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos
139 [GO] 2021―Apr―16 Progress in research on the S protein as the target of COVID-19 vaccines Mohnad Abdalla, Amr Ahmed El-Arabey, Xinyi Jiang
140 [GO] 2021―Apr―16 Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies Lianlian Bian, Fan Gao, Jialu Zhang, Qian He, Qunying Mao, Miao Xu, Zhenglun Liang
141 [GO] 2021―Mar―31 Is SARS-CoV-2 vaccination safe and effective for elderly individuals with neurodegenerative diseases? Yan Shi, Minna Guo, Wenjing Yang, Shijiang Liu, Bin Zhu, Ling Yang, et al. (+2)
142 [GO] 2021―Mar―22 Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19. Rick Heida, Wouter LJ Hinrichs, Henderik W Frijlink
143 [GO] 2021―Mar―20 Letter to the editor to: Verger P and Dubé E. Restoring confidence in vaccines in the COVID-19 era, Expert Review of Vaccines, 2020; 19(11):991-3 Iman Ridda, Richard Chamberlain, Rita Haber, Harunor Rashid
144 [GO] 2021―Feb―18 COVID-19 and the rise of anti-science Peter Hotez
145 [GO] 2021―Feb―17 Improving pandemic preparedness through better, faster influenza vaccines Matthew Newland, David Durham, Jason Asher, John J. Treanor, Jonathan Seals, Ruben O. Donis, Robert Johnson
146 [GO] 2021―Feb―08 Latin American forum on immunization services during the COVID-19 pandemic María L. Ávila-Agüero, Sebastián Ospina-Henao, María C. Pirez, Ángela Gentile, Soraya Araya, José Brea, et al. (+2)
147 [GO] 2021―Jan―15 Immunoinformatics-guided Designing and In Silico Analysis of Epitope-based Polyvalent Vaccines against Multiple Strains of Human Coronavirus (HCoVs) Bishajit Sarkar, Asad Ullah, Yusha Araf, Nafisa Nawal Islam, Umme Salma Zohora
148 [GO] 2021―Jan―15 COVID-19 vaccine: where are we now and where should we go? Saman Soleimanpour, Atieh Yaghoubi
149 [GO] 2020―Nov―30 Why METH users are at high risk of fatality due to COVID-19 infection? Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos
150 [GO] 2020―Nov―28 Research progress in the development of porcine reproductive and respiratory syndrome virus as a viral vector for foreign gene expression and delivery Guo Dai, Mei Huang, To Sing Fung, Ding Xiang Liu
151 [GO] 2020―Oct―27 COVID-19 in healthcare workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines Rémi Labetoulle, Maëlle Detoc, Julie Gagnaire, Philippe Berthelot, Carole Pelissier, Luc Fontana, et al. (+2)
152 [GO] 2020―Sep―23 “Mindful” development of rapid, safe and effective COVID-19 vaccines Leonard Moise, Ted M. Ross, Daniel F. Hoft, William D. Martin, Anne S. De Groot
153 [GO] 2020―Sep―18 How can a global pandemic affect vaccine hesitancy? Eve Dubé, Noni E MacDonald
154 [GO] 2020―Sep―17 Restoring confidence in vaccines in the COVID-19 era Pierre Verger, Eve Dubé
155 [GO] 2020―Sep―17 Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks and public health considerations Janet Sultana, Giampiero Mazzaglia, Nicoletta Luxi, Antonino Cancellieri, Annalisa Capuano, Carmen Ferrajolo, et al. (+3)
156 [GO] 2020―Sep―01 Designing an Efficient Multi-Epitope Vaccine Displaying Interactions with Diverse HLA Molecules for an Efficient Humoral and Cellular Immune Response to prevent COVID-19 infection. Mrutyunjay Suar, Soumya Mahapatra, Susrita Sahoo, Budheswar Dehury, Vishakha Raina, Shubhransu Patro, Namrata Misra
157 [GO] 2020―Aug―26 An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies Naru Zhang, Jian Shang, Chaoqun Li, Kehui Zhou, Lanying Du
158 [GO] 2020―Aug―25 Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns Raphaël M. Zellweger, T. Anh Wartel, Florian Marks, Manki Song, Jerome H. Kim
159 [GO] 2020―Aug―20 Exploring the SARS-CoV-2 structural proteins for Multi-Epitope vaccine development: an in-silico approach Amit Kumar, Prateek Kumar, Kumar Udit Saumya, Shivani K. Kapuganti, Taniya Bhardwaj, Rajanish Giri
160 [GO] 2020―Aug―06 The potential impact of COVID-19 pandemic on the immunization performance in Indonesia Auliya A. Suwantika, Cornelis Boersma, Maarten J. Postma
 [1] 

160 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec